Changeflow GovPing Pharma & Drug Safety African Swine Fever Virus Vaccine Compositions
Routine Notice Added Final

African Swine Fever Virus Vaccine Compositions

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published a patent application (EP2026030491A1) for African Swine Fever Virus vaccine compositions and methods of making and using them. The publication date is March 18, 2026. The inventors have not yet been designated.

What changed

The European Patent Office (EPO) has published patent application EP2026030491A1 concerning African Swine Fever Virus vaccine compositions. This application details methods for making and using these vaccine compositions. The publication date is March 18, 2026, and it is designated for various European states.

This publication represents a new patent filing and does not impose immediate compliance obligations. However, companies involved in veterinary vaccine development or manufacturing should be aware of this filing as it pertains to potential intellectual property in the field of African Swine Fever prevention. Further monitoring of the patent prosecution process is recommended to determine if a granted patent will issue.

Source document (simplified)

← EPO Patent Bulletin

AFRICAN SWINE FEVER VIRUS VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Publication EP2026030491A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

A61K 39/12 20060101AFI20260207BHEP A61P 31/20 20060101ALI20260207BHEP C12N 7/04 20060101ALI20260207BHEP G01N 33/577 20060101ALI20260207BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Named provisions

AFRICAN SWINE FEVER VIRUS VACCINE COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030491A1

Who this affects

Applies to
Drug manufacturers Pharmaceutical companies
Industry sector
3254 Pharmaceutical Manufacturing
Activity scope
Vaccine Development
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Veterinary Medicine

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.